RxDoctor Payments Data

Lindsey Hobson

Acute Care · Richmond, INNPI 1497990295

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,968 of the $4,467 with a category attached, or 66.4%. 38 manufacturers reported payments, led by Edwards Lifesciences at 39.9% of the total. Reporting peaked in 2022 at $1,914 and has fallen 56.2% since, to $838 in 2025. Among acute care clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,467in general payments, 2019–2025

Across 146 payments — averaging $30.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$2K
  • AstraZeneca$484
  • Chiesi USA, Inc.$308
  • Astellas Pharma US Inc$198
  • Novartis$163
  • Boehringer Ingelheim$151
  • plus $1K from 32 others

What the payments were for

  • Consulting fees$2506%
  • Travel & lodging$88020%
  • Food & beverage$2,96866%
  • Education$2957%
  • Gifts$752%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,467 in reported general payments places this provider in the 90th percentile of 240 acute care providers in Indiana.

See all acute care providers in Indiana

Medicare billing

Part B allowed, 2024
$12,864
Medicare patients
86
Services billed
151

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mupirocin25$182
Amiodarone Hcl16$90
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$89
Atorvastatin Calcium18$84
Metoprolol Tartrate31$75
Potassium Chloride12$61
Metoprolol Succinate13$40
Furosemide23$35

Paid to pharmacies, not to this prescriber.

Other acute care in Richmond

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →